SRSA
TMO icon

S.R. Schill & Associates’s Thermo Fisher Scientific TMO Stock Holding History

S.R. Schill & Associates’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-565
Closed -$350K – 36
2024
Q3 		$350K Sell
565
-1,622
-74% -$960K 0.25% 25
2024
Q2 		$1.21M Buy
2,187
+857
+64% +$491K 0.53% 23
2024
Q1 		$773K Sell
1,330
-207
-13% -$116K 0.34% 35
2023
Q4 		$816K Buy
1,537
+792
+106% +$383K 0.36% 30
2023
Q3 		$377K Sell
745
-70
-9% -$37.3K 0.18% 56
2023
Q2 		$425K Buy
815
+325
+66% +$175K 0.19% 47
2023
Q1 		$282K Buy
490
+9
+2% +$5.07K 0.13% 62
2022
Q4 		$265K Sell
481
-128
-21% -$67.8K 0.13% 65
2022
Q3 		$309K Buy
609
+103
+20% +$57.6K 0.16% 47
2022
Q2 		$275K Buy
+506
New +$279K 0.14% 53
2022
Q1 		– Sell
-385
Closed -$257K – 80
2021
Q4 		$257K Buy
385
+20
+5% +$12.5K 0.1% 69
2021
Q3 		$209K Buy
+365
New +$200K 0.09% 85
2021
Q2 		– Sell
-1,700
Closed -$776K – 96
2021
Q1 		$776K Buy
1,700
+213
+14% +$102K 0.34% 38
2020
Q4 		$693K Buy
1,487
+432
+41% +$203K 0.32% 38
2020
Q3 		$466K Sell
1,055
-524
-33% -$216K 0.24% 47
2020
Q2 		$572K Buy
1,579
+64
+4% +$21.5K 0.33% 41
2020
Q1 		$430K Sell
1,515
-455
-23% -$143K 0.29% 41
2019
Q4 		$640K Buy
1,970
+4
+0.2% +$1.21K 0.35% 46
2019
Q3 		$573K Sell
1,966
-1
-0.1% -$286 0.32% 45
2019
Q2 		$578K Buy
1,967
+586
+42% +$161K 0.36% 46
2019
Q1 		$378K Sell
1,381
-29
-2% -$7.22K 0.23% 61
2018
Q4 		$316K Sell
1,410
-12
-0.8% -$2.81K 0.22% 62
2018
Q3 		$347K Buy
+1,422
New +$327K 0.21% 67

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

S.R. Schill & Associates's TMO Position: Q4 2024 in Review

S.R. Schill & Associates sold out of Thermo Fisher Scientific (TMO) in Q4 2024, closing a stake of 565 shares — an estimated $350K sold.

S.R. Schill & Associates first reported a position in TMO in Q3 2018 and held it in 23 quarters. The position peaked at $1.21M in Q2 2024. 2,617 funds tracked by Wall St. Rank hold TMO as of Q4 2024.

  • S.R. Schill & Associates reported no remaining Thermo Fisher Scientific position as of Q4 2024 after selling out during the quarter.
  • S.R. Schill & Associates sold 565 Thermo Fisher Scientific shares in Q4 2024, an estimated $350K.
  • S.R. Schill & Associates first reported a position in Thermo Fisher Scientific in Q3 2018 and held it in 23 quarters.
  • S.R. Schill & Associates's Thermo Fisher Scientific position peaked at $1.21M in Q2 2024.
  • 2,617 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2024.

Based on S.R. Schill & Associates's 13F filing for Q4 2024, filed 22 Jan 2025.